A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/18 (2006.01) A61K 33/24 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2265547
The use of human erythropoietin (EPO) to prevent or treat endothelial injury due to chemotherapy, radiation therapy, mechanical trauma, or to a disease state which damages the endothelium (such as inflammation, heart disease or cancer) is described. The use of EPO in conjuction with the administration of chemotherapeutic agents is described.
Cette invention concerne l'utilisation d'érythropoïétine (EPO) humaine pour prévenir ou traiter les lésions endothéliales dues à la chimiothérapie, à la radiothérapie, à des traumatismes mécaniques ou à un état pathologique qui endommage l'endothélium (tel que l'inflammation, les maladies cardiaques ou le cancer). Dans cette invention on utilise l'érythropoïétine en conjonction avec l'administration d'agents chimiothérapeutiques.
Anagnostou Athanasius A.
Sigounas George
East Carolina University
Sim & Mcburney
LandOfFree
Method of treating endothelial injury does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating endothelial injury, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating endothelial injury will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1558986